QuidelOrtho Corporation (QDEL) vs Rigel Pharmaceuticals, Inc. (RIGL)
A side-by-side comparison of QuidelOrtho Corporation and Rigel Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
QDEL
QuidelOrtho Corporation
$12.46HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
RIGL
Rigel Pharmaceuticals, Inc.
$46.50HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
Total return — QDEL vs RIGL
growth of $100 · dividends reinvested · last 10yQDEL -43.9% (-5.6%/yr)RIGL +26.8% (+2.4%/yr)RIGL compounded faster over this window
QDEL RIGL
QDEL vs RIGL: by the numbers
- •RIGL is the larger company ($860M vs $850M market cap).
- •RIGL is profitable (116.30% net margin) while QDEL runs a net loss (-39.20%).
- •RIGL grew revenue faster over the past five years (13.94% vs 7.14% CAGR).
Metrics side by side
Valuation
| Metric | QDEL | RIGL |
|---|---|---|
| P/E ratio | N/A | 2.85 |
| Forward P/E | 16.13 | 13.56 |
| P/S ratio | 0.32 | 3.11 |
| P/B ratio | 0.48 | 2.02 |
| EV / EBITDA | N/A | 9.36 |
| FCF yield | N/A | 9.23% |
Profitability
| Metric | QDEL | RIGL |
|---|---|---|
| Gross margin | 44.60% | 91.39% |
| Operating margin | -30.67% | 42.63% |
| Net margin | -39.20% | 116.30% |
| ROE | -59.07% | 75.67% |
| ROIC | -16.05% | 18.72% |
Growth (annualized)
| Metric | QDEL | RIGL |
|---|---|---|
| Revenue CAGR (5Y) | 7.14% | 13.94% |
| Total return CAGR (5Y) | -38.12% | 6.25% |
Frequently asked
- Which has grown faster, QDEL or RIGL?
- Over the past five years, RIGL grew revenue faster — QDEL at a 7.14% CAGR versus RIGL at 13.94%.
- Is QDEL or RIGL more profitable?
- RIGL runs the higher net margin — QDEL at -39.20% versus RIGL at 116.30%.
- How have QDEL and RIGL total returns compared?
- Over the past 10 years, QDEL delivered -5.68% and RIGL delivered 1.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Rigel Pharmaceuticals P/E ratioQuidelOrtho ROERigel Pharmaceuticals ROEQuidelOrtho operating marginRigel Pharmaceuticals operating marginQuidelOrtho revenue growthRigel Pharmaceuticals revenue growthQuidelOrtho free cash flowRigel Pharmaceuticals free cash flow
QuidelOrtho & Rigel Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.